ES265825A1 - Un metodo para la producciën de 3-ceto-delta-4,6-alfa-trifluorometil-esteroides y 3-ceto-delta-1,4-6 alfa-trifluorometil-esteroides de la serie del androstano, de la del pergnano, de la serie de 19-nor-androstano y de la serie de 19-nor-pregnano y su - Google Patents

Un metodo para la producciën de 3-ceto-delta-4,6-alfa-trifluorometil-esteroides y 3-ceto-delta-1,4-6 alfa-trifluorometil-esteroides de la serie del androstano, de la del pergnano, de la serie de 19-nor-androstano y de la serie de 19-nor-pregnano y su

Info

Publication number
ES265825A1
ES265825A1 ES0265825A ES265825A ES265825A1 ES 265825 A1 ES265825 A1 ES 265825A1 ES 0265825 A ES0265825 A ES 0265825A ES 265825 A ES265825 A ES 265825A ES 265825 A1 ES265825 A1 ES 265825A1
Authority
ES
Spain
Prior art keywords
series
keto
trifluoromethyl
alpha
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0265825A
Other languages
English (en)
Spanish (es)
Inventor
Godtfredsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma AS filed Critical Leo Pharma AS
Publication of ES265825A1 publication Critical patent/ES265825A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
ES0265825A 1960-03-18 1961-03-17 Un metodo para la producciën de 3-ceto-delta-4,6-alfa-trifluorometil-esteroides y 3-ceto-delta-1,4-6 alfa-trifluorometil-esteroides de la serie del androstano, de la del pergnano, de la serie de 19-nor-androstano y de la serie de 19-nor-pregnano y su Expired ES265825A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9758/60A GB905694A (en) 1960-03-18 1960-03-18 6-trifluoromethylsteroids and method for their production
GB2019060 1960-06-08

Publications (1)

Publication Number Publication Date
ES265825A1 true ES265825A1 (es) 1961-10-16

Family

ID=26243151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0265825A Expired ES265825A1 (es) 1960-03-18 1961-03-17 Un metodo para la producciën de 3-ceto-delta-4,6-alfa-trifluorometil-esteroides y 3-ceto-delta-1,4-6 alfa-trifluorometil-esteroides de la serie del androstano, de la del pergnano, de la serie de 19-nor-androstano y de la serie de 19-nor-pregnano y su

Country Status (8)

Country Link
US (1) US3222383A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT248619B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE601534A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH399446A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES265825A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR1555454A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB905694A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE220240C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE658878A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1964-01-27
BE667120A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1965-04-09
CN114075259B (zh) * 2020-08-14 2024-04-12 保定九孚生化有限公司 一种醋酸可的松母液的回收方法

Also Published As

Publication number Publication date
AT248619B (de) 1966-08-10
CH399446A (de) 1965-09-30
SE220240C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1968-04-30
GB905694A (en) 1962-09-12
US3222383A (en) 1965-12-07
BE601534A (fr) 1961-09-20
FR1555454A (fr) 1969-01-31

Similar Documents

Publication Publication Date Title
GB1087317A (en) New, highly active estrogenic 17-oxo-steroids and process for their manufacture
ES265825A1 (es) Un metodo para la producciën de 3-ceto-delta-4,6-alfa-trifluorometil-esteroides y 3-ceto-delta-1,4-6 alfa-trifluorometil-esteroides de la serie del androstano, de la del pergnano, de la serie de 19-nor-androstano y de la serie de 19-nor-pregnano y su
ES301833A1 (es) Un procedimiento para la prepación de 19-alkil-esteroides
GB1058543A (en) 16-methylene-steroids
ES268064A1 (es) Un metodo para la producciën de esteroides de 3-ceto-delta4,6-6-trifluorometilo y esteroides de 3-ceto-delta1,4,6-6-trifluorometilo de las series androstano, de la serie 19-nor-androstano y de la serie 19-nor-pregnano
GB1001858A (en) Improvements in and relating to 17ª‡-alkoxy-steroids
GR22811B (el) Μεθοδος δια την παρασκευην των 6α-τριφθορο-μεθυλοστερινων.
SE333730B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES276465A1 (es) Procedimiento de preparación de derivados de la 19-nor-testosterona
GB841003A (en) Improvements in or relating to 6-methyl steroid compounds
GB804523A (en) Steroids and the preparation thereof
GB723697A (en) Improvements in the preparation of 3:17-diols of the cyclopentanopolyhydrophenanthrene series
GB948114A (en) Steroids and production thereof
GB855801A (en) New cyclopentanophenanthrene derivatives and process for the production thereof
ES388784A1 (es) Un procedimiento de preparacion de la 17 alfa - hidroxi - pregna - 4,9 (11)-dieno - 3,20 - diona.
ES364018A1 (es) Procedimiento para la preparacion de nuevos derivados de 18-metil-5 alfa-h-androstano.
GB1078174A (en) 6-substituted pregnane compounds
GB1151209A (en) Pentacyclic Steroid Intermediates and Method of Preparing the same
GB969904A (en) 11ª‰-and 14ª‡-hydroxylated 16ª‡-methyl steroids and process for their manufacture
GB802566A (en) Improvements in or relating to a steroid and the manufacture thereof
GB1277759A (en) Gona-3,5-dienes
DK77688C (da) Fremgangsmåde til omdannelse af ketogruppen i monoketoner af cyklopentanopolyhydrofenantrenrækken til en forestret hydroxylgruppe.
GR21274B (el) Μεθοδος παρασκευης του υδροξυμεθυλο - 2 χλωρο - 4φαινοξυοξικου οξεος.
GB1098283A (en) Process for dehydrogenating a-nor-b-homo-steroids
GB1023786A (en) Process for the manufacture of cyclic hemi-acetals